Something PLM to say?

PLM expert? Want to have your say? I'd definitely be interested in hearing from people who want to make regular contributions to this blog. What I'm really looking for is people who have thoughts on the general state of PLM, not just technical info.

So, drop me an email at sam.carling0@googlemail.com

Pharma + PLM = regulatory compliance

It was interesting to read yesterday that there has been above average growth in the adoption of PLM in the pharmaceutical industry.

The main reason seems to be that PLM provides a great set of tools to manage the regulatory hoops that pharma companies now have to jump through in order to be compliant with a host of international mandates.

There is also an obvious benefit with PLM’s ability to streamline collaboration through the development of a new product to get it to market as quickly as possible. In a way, the compliance issues have made speed to market even more important due to the additional costs incurred as a result. Datamonitor put PLM spend by pharma companies at almost US$500 million in 2007.

You can view the full article on the MBT website.

One element of this article that I thought was especially interesting was the point that PLM needs to be viewed strategically – see my previous post on ‘What PLM is...’.

IBM Predicts Continued PLM Growth

For those of you that missed it, IBM has reiterated its confidence in PLM. The general gist of the news is that it sees PLM becoming a much broader enterprise-wide set of tools with increased collaboration, and as such plans to continue its expansion. Currently IBM has 10 centres of excellence for PLM around the World, plus a few other bits and pieces – which in total is about 3,000 PLM professionals.